RMR Real Estate Income Fund Kapitalrendite
Was ist das Kapitalrendite von RMR Real Estate Income Fund?
Kapitalrendite von RMR Real Estate Income Fund ist 29.12%
Was ist die Definition von Kapitalrendite?
Die Eigenkapitalrendite ist ein Maß für die Rentabilität eines Unternehmens im Verhältnis zum Buchwert des Eigenkapitals. Sie wird berechnet, indem das Nettoergebnis des Geschäftsjahres durch das gesamte Eigenkapital geteilt wird.
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Kapitalrendite von Unternehmen in Finance Sektor auf NYSEMKT im Vergleich zu RMR Real Estate Income Fund
Was macht RMR Real Estate Income Fund?
RMR Real Estate Income Fund is a closed-end investment fund/investment trust. Its objective is to earn and pay to its common shareholders a high level of current income by investing in real estate companies. The company was founded in 2003 and is headquartered in Newton, MA.
Unternehmen mit kapitalrendite ähnlich RMR Real Estate Income Fund
- The Westaim hat Kapitalrendite von 29.09%
- CNH Industrial NV hat Kapitalrendite von 29.09%
- BlackRock Latin American Investment Trust Plc hat Kapitalrendite von 29.09%
- CSX hat Kapitalrendite von 29.11%
- Aptech hat Kapitalrendite von 29.11%
- PS Business Parks hat Kapitalrendite von 29.11%
- RMR Real Estate Income Fund hat Kapitalrendite von 29.12%
- Sport Lisboa e Benfica - Futebol, SAD hat Kapitalrendite von 29.12%
- Gayatri Highways hat Kapitalrendite von 29.13%
- Genpact Ltd hat Kapitalrendite von 29.14%
- The Mosaic hat Kapitalrendite von 29.14%
- ASE Technology Co.Ltd hat Kapitalrendite von 29.16%
- Suven Life Sciences hat Kapitalrendite von 29.17%